{"id":27355,"date":"2025-04-22T16:27:41","date_gmt":"2025-04-22T23:27:41","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27355"},"modified":"2025-04-22T16:27:43","modified_gmt":"2025-04-22T23:27:43","slug":"ivig-for-birdshot-retinochoroidopathy-bsrc","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/","title":{"rendered":"IgIV para la retinocoroidopat\u00eda en perdigones (BSRC)"},"content":{"rendered":"<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/understanding-birdshot-retinochoroidopathy-symptoms-diagnosis-and-treatment-options\/\">Retinocoroidopat\u00eda en perdigones<\/a> (BRSC), tambi\u00e9n conocida por otros t\u00e9rminos como uve\u00edtis en perdigones, coriorretinopat\u00eda en perdigones o uve\u00edtis HLA-A29, es una enfermedad rara y potencialmente mortal que afecta a ambos ojos y puede provocar una p\u00e9rdida permanente de la visi\u00f3n si no se trata a tiempo.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-fc53020e3ea38080861e1d678324a1ce\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tPregunte sobre la infusi\u00f3n de IgIV en el hogar\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\"> (877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Dado que no existe cura para el BSRC, se utilizan corticosteroides o f\u00e1rmacos inmunosupresores como tratamiento est\u00e1ndar para controlar la afecci\u00f3n en las personas afectadas. Sin embargo, algunos pacientes experimentan efectos secundarios graves con estos medicamentos y buscan tratamientos alternativos. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\">inmunoglobulina intravenosa (IVIG)<\/a> infusiones.&nbsp;<\/p>\n\n\n\n<p>La terapia con IgIV ha demostrado ser eficaz en el tratamiento de los s\u00edntomas de BSRC en muchos pacientes, especialmente en aquellos que no responden bien al tratamiento est\u00e1ndar (es decir, corticosteroides o medicamentos inmunosupresores).&nbsp;<\/p>\n\n\n\n<p>Contin\u00fae leyendo para conocer c\u00f3mo la IgIV puede ayudar a los pacientes con coriorretinopat\u00eda en perdigones, c\u00f3mo funciona esta terapia y qu\u00e9 puede esperar durante el tratamiento con IgIV.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#Birdshot_Retinochoroidopathy_Brief_Overview\" >Retinocoroidopat\u00eda en perdigones: breve descripci\u00f3n general<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#IVIG_Therapy_and_Birdshot_Retinochoroidopathy_Clinical_Evidence\" >Terapia con IgIV y retinocoroidopat\u00eda en perdigones: evidencia cl\u00ednica<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#How_Does_IVIG_Work_in_Patients_With_Birdshot_Retinochoroidopathy\" >\u00bfC\u00f3mo funciona la IgIV en pacientes con retinocoroidopat\u00eda en perdigones?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#IVIG_and_Mechanisms_of_Action\" >IgIV y mecanismos de acci\u00f3n<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#1_It_Modulates_the_T_Cell_Activity\" >1. Modula la actividad de las c\u00e9lulas T\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#2_It_Blocks_the_Activity_of_Autoantibodies\" >2. Bloquea la actividad de los autoanticuerpos.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#3_It_Reduces_Intraocular_Inflammation\" >3. Reduce la inflamaci\u00f3n intraocular<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#4_It_Enhances_the_Function_of_Regulatory_T_Cells\" >4. Mejora la funci\u00f3n de las c\u00e9lulas T reguladoras\u00a0<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#Benefits_of_IVIG_for_Patients_With_Birdshot_Retinochoroidopathy\" >Beneficios de la IgIV para pacientes con retinocoroidopat\u00eda en perdigones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#What_Can_You_Expect_During_IVIG_Treatment\" >\u00bfQu\u00e9 puede esperar durante el tratamiento con IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#Takeaway\" >Llevar<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-birdshot-retinochoroidopathy-brief-overview\"><span class=\"ez-toc-section\" id=\"Birdshot_Retinochoroidopathy_Brief_Overview\"><\/span>Retinocoroidopat\u00eda en perdigones: breve descripci\u00f3n general<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La retinocoroidopat\u00eda en perdigones es una enfermedad ocular cr\u00f3nica (a largo plazo) causada por un ataque anormal al sistema inmunitario. Tambi\u00e9n se conoce como trastorno autoinmunitario mediado por linfocitos T. Estos linfocitos desencadenan una respuesta inmunitaria contra la retina y la coroides, dos componentes importantes del ojo responsables de la visi\u00f3n.&nbsp;<\/p>\n\n\n\n<p>Las investigaciones han demostrado que la activaci\u00f3n de las c\u00e9lulas T es <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7687429\/#:~:text=In%20two%20genome%2Dwide%20association,mediated%20by%20additional%20etiological%20triggers.\">fuertemente asociado<\/a> con el alelo del ant\u00edgeno leucocitario humano (HLA) A29, y m\u00e1s de <a href=\"https:\/\/www.mdpi.com\/2077-0383\/11\/16\/4772\">95% de pacientes de BSRC<\/a> son portadores de esta variante gen\u00e9tica.&nbsp;<\/p>\n\n\n\n<p>El HLA-A29 activa las c\u00e9lulas T citot\u00f3xicas, que atacan los tejidos retinianos y coroideos, lo que provoca inflamaci\u00f3n y da\u00f1o progresivos. Como resultado, los pacientes con retinocoroidopat\u00eda en perdigones experimentan alteraciones visuales como visi\u00f3n borrosa, miodesopsias (peque\u00f1as manchas m\u00f3viles en el campo visual) y p\u00e9rdida de la visi\u00f3n perif\u00e9rica con el tiempo.&nbsp;<\/p>\n\n\n\n<p>En resumen, la gen\u00e9tica, junto con el sistema inmunitario, es responsable de la aparici\u00f3n de esta enfermedad. Adem\u00e1s, la retinocoroidopat\u00eda en perdigones es una enfermedad cr\u00f3nica; por lo tanto, las personas afectadas requieren tratamiento a largo plazo para retrasar la progresi\u00f3n de la enfermedad y preservar la visi\u00f3n.&nbsp;&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-therapy-and-birdshot-retinochoroidopathy-clinical-evidence\"><span class=\"ez-toc-section\" id=\"IVIG_Therapy_and_Birdshot_Retinochoroidopathy_Clinical_Evidence\"><\/span>Terapia con IgIV y retinocoroidopat\u00eda en perdigones: evidencia cl\u00ednica<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10806434\/\">informe de caso<\/a> Un estudio publicado en la revista \u00abOcular Immunology and Inflammation\u00bb destac\u00f3 los efectos positivos de la inmunoglobulina intravenosa (IVIG) en el tratamiento de la uve\u00edtis en perdigones. El estudio revel\u00f3 que los pacientes que no respondieron a los tratamientos habituales, como inmunosupresores o esteroides, experimentaron mejoras significativas en la visi\u00f3n tras recibir la terapia con IVIG. El r\u00e9gimen de tratamiento consisti\u00f3 en la administraci\u00f3n de IGIV a una dosis de 1,6 g\/kg cada 4 semanas durante 6 meses, seguida de infusiones de 1,2 a 1,6 g\/kg con intervalos de 6 a 8 semanas.<\/p>\n\n\n\n<p>De manera similar, otro <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11965114\/\">informe de caso<\/a> En un estudio de 18 pacientes con retinocoroidopat\u00eda activa en perdigones, se observ\u00f3 que, tras infusiones de IgIV, 53% mostr\u00f3 una mejora significativa de la visi\u00f3n, mientras que 29% se mantuvo estable. Adem\u00e1s,<strong> <\/strong>La inflamaci\u00f3n ocular se redujo en<strong> <\/strong>81% de pacientes, y<strong> <\/strong>La hinchaz\u00f3n macular (edema) mejor\u00f3 en el 65% de los casos.<\/p>\n\n\n\n<p>Este y varios otros peque\u00f1os <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S000293949900029X#:~:text=Intravenous%20immunoglobulin%20(IVIg)%20effectively%20treats,controlled%20trials%20that%20demonstrate%20efficacy.\">estudios de caso<\/a>, informaron que la IgIV podr\u00eda ser un tratamiento seguro y potencialmente eficaz para la uve\u00edtis en perdigones cuando los tratamientos est\u00e1ndar son refractarios. Sin embargo, los ensayos cl\u00ednicos a gran escala son limitados en cuanto al uso a largo plazo de la terapia con IgIV en pacientes con retinocoroidopat\u00eda en perdigones.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-ivig-work-in-patients-with-birdshot-retinochoroidopathy\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Work_in_Patients_With_Birdshot_Retinochoroidopathy\"><\/span>\u00bfC\u00f3mo funciona la IgIV en pacientes con retinocoroidopat\u00eda en perdigones?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El mecanismo exacto de la terapia con IgIV para el manejo de esta enfermedad autoinmune no est\u00e1 claro. Sin embargo, varios estudios de caso han reportado que la IgIV tiene m\u00faltiples mecanismos de acci\u00f3n que pueden ayudar a retardar la p\u00e9rdida de visi\u00f3n y reducir la inflamaci\u00f3n y los brotes en pacientes con BSRC.<\/p>\n\n\n\n<div  id=\"call-to-action-1bc9e6f60a76177d278493a3104466b3\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAsistencia financiera para la IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Empezar<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-and-mechanisms-of-action\"><span class=\"ez-toc-section\" id=\"IVIG_and_Mechanisms_of_Action\"><\/span>IgIV y mecanismos de acci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"400\" height=\"267\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm.jpg\" alt=\"Arm of patient receiving IVIG\" class=\"wp-image-27360\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm.jpg 400w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-arm-370x247.jpg 370w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><\/figure>\n<\/div>\n\n\n<p>La terapia con IgIV administra inmunoglobulinas (anticuerpos) derivadas del plasma acumulado de miles de donantes sanos. Estos anticuerpos regulan el sistema inmunitario, ya sea manteniendo los niveles de IgG en pacientes con inmunodeficiencia o calmando la hiperactividad del sistema inmunitario en pacientes con enfermedades autoinmunes.&nbsp;<\/p>\n\n\n\n<p>En el caso de la retinocoroidopat\u00eda en perdigones, que tambi\u00e9n es una enfermedad autoinmune, la IgIV ayuda a suprimir el sistema inmunitario hiperactivo para evitar que las c\u00e9lulas inmunitarias sigan da\u00f1ando los tejidos retinianos. En estos pacientes, la IgIV puede actuar de varias maneras:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-1-it-modulates-the-t-cell-activity\"><span class=\"ez-toc-section\" id=\"1_It_Modulates_the_T_Cell_Activity\"><\/span>1. <strong>Modula la actividad de las c\u00e9lulas T\u00a0<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La IgIV suprime la hiperactividad de los linfocitos T y reduce la respuesta inmunitaria contra los tejidos retinianos y coroideos. En resumen, la IgIV previene da\u00f1os adicionales.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-2-it-blocks-the-activity-of-autoantibodies\"><span class=\"ez-toc-section\" id=\"2_It_Blocks_the_Activity_of_Autoantibodies\"><\/span>2. Bloquea la actividad de los autoanticuerpos.<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los anticuerpos proporcionados durante el tratamiento con IgIV neutralizan el efecto de los autoanticuerpos da\u00f1inos y evitan que ataquen los tejidos de la retina.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-it-reduces-intraocular-inflammation\"><span class=\"ez-toc-section\" id=\"3_It_Reduces_Intraocular_Inflammation\"><\/span>3. Reduce la inflamaci\u00f3n intraocular<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La IgIV tiene efectos antiinflamatorios que ayudan a reducir la inflamaci\u00f3n intraocular (inflamaci\u00f3n que ocurre dentro del ojo) al disminuir las se\u00f1ales inflamatorias (IL-17 e IFN-\u03b3) y promover la liberaci\u00f3n de citocinas antiinflamatorias (mol\u00e9culas que reducen la inflamaci\u00f3n). Esto tambi\u00e9n reduce potencialmente la necesidad de tratamiento con esteroides y otros inmunosupresores.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-4-it-enhances-the-function-of-regulatory-t-cells\"><span class=\"ez-toc-section\" id=\"4_It_Enhances_the_Function_of_Regulatory_T_Cells\"><\/span>4. Mejora la funci\u00f3n de las c\u00e9lulas T reguladoras\u00a0<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Normalmente, las c\u00e9lulas T reguladoras (tambi\u00e9n llamadas Tregs) suprimen la respuesta inmunitaria excesiva. Sin embargo, en el caso del BSRC, estas c\u00e9lulas no funcionan correctamente y contribuyen a la actividad descontrolada de las c\u00e9lulas T y a la inflamaci\u00f3n cr\u00f3nica.&nbsp;<\/p>\n\n\n\n<p>La terapia con IgIV mejora la actividad de las c\u00e9lulas T reguladoras, que ayudan a prevenir ataques autoinmunes y la inflamaci\u00f3n.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-benefits-of-ivig-for-patients-with-birdshot-retinochoroidopathy\"><span class=\"ez-toc-section\" id=\"Benefits_of_IVIG_for_Patients_With_Birdshot_Retinochoroidopathy\"><\/span>Beneficios de la IgIV para pacientes con retinocoroidopat\u00eda en perdigones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A diferencia de los tratamientos est\u00e1ndar para la retinocoroidopat\u00eda en perdigones, la IgIV ofrece varios beneficios a los pacientes, tales como:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Generalmente es bien tolerado y tiene menos efectos secundarios que los esteroides y los medicamentos inmunosupresores (como metotrexato, micofenolato mofetilo o agentes anti-TNF) que pueden causar aumento de peso, osteoporosis, diabetes o toxicidad hep\u00e1tica y renal.\u00a0<\/li>\n\n\n\n<li>Tiene efectos duraderos (se administra cada 3 o 4 semanas) en comparaci\u00f3n con los medicamentos BSRC tradicionales que normalmente se requieren a diario.<\/li>\n\n\n\n<li>Es m\u00e1s eficaz, especialmente en pacientes que no responden a las terapias convencionales.\u00a0<\/li>\n\n\n\n<li>Reduce la inflamaci\u00f3n intraocular y previene una mayor p\u00e9rdida de visi\u00f3n al suprimir la respuesta inmune hiperactiva.\u00a0<\/li>\n<\/ol>\n\n\n\n<p><strong>Nota<\/strong>La respuesta individual al tratamiento con IgIV puede variar significativamente. Si bien algunos pacientes pueden experimentar una r\u00e1pida mejor\u00eda en cuesti\u00f3n de semanas, otros pueden requerir tratamientos m\u00e1s prolongados para lograr resultados \u00f3ptimos.<\/p>\n\n\n\n<div  id=\"call-to-action-f69b3f25bab3b0bb13e630c7a19fb23f\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfPuede ayudar la IgIV?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n gratuita sobre el tratamiento con IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-can-you-expect-during-ivig-treatment\"><span class=\"ez-toc-section\" id=\"What_Can_You_Expect_During_IVIG_Treatment\"><\/span>\u00bfQu\u00e9 puede esperar durante el tratamiento con IgIV?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Durante el tratamiento con IgIV, su profesional de la salud le administrar\u00e1 el medicamento mediante una infusi\u00f3n intravenosa (IV). El proceso de infusi\u00f3n suele tardar de 2 a 6 horas y se repite cada 3 o 4 semanas, seg\u00fan su respuesta.\u00a0<\/p>\n\n\n\n<p>Es posible que experimente algunos s\u00edntomas leves. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/understanding-the-common-side-effects-of-ivig-treatment\/\">efectos secundarios<\/a> como <strong>dolor de cabeza, fatiga, fiebre o n\u00e1useas<\/strong> Durante o despu\u00e9s de las infusiones de IgIV. Consulte a su m\u00e9dico si presenta alguno de estos s\u00edntomas.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-takeaway\"><span class=\"ez-toc-section\" id=\"Takeaway\"><\/span>Llevar<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La retinocoroidopat\u00eda en perdig\u00f3n es una enfermedad ocular rara pero cr\u00f3nica que requiere tratamiento a largo plazo para prevenir la p\u00e9rdida de visi\u00f3n. Si bien los tratamientos convencionales, como los corticosteroides y los inmunosupresores, siguen siendo el tratamiento de referencia, la terapia con IgIV puede utilizarse como tratamiento alternativo para pacientes con enfermedades resistentes al tratamiento o que no toleran las terapias est\u00e1ndar.&nbsp;<\/p>\n\n\n\n<p>Si usted o su ser querido est\u00e1 interesado en la IgIV, debe analizar los riesgos, los beneficios y la accesibilidad con su oftalm\u00f3logo e inmun\u00f3logo antes de cambiar a la IgIV.<\/p>","protected":false},"excerpt":{"rendered":"<p>La retinocoroidopat\u00eda en perdigones (BRSC), tambi\u00e9n conocida por otros t\u00e9rminos como uve\u00edtis en perdigones, coriorretinopat\u00eda en perdigones o uve\u00edtis HLA-A29, es una enfermedad poco com\u00fan y potencialmente mortal para la visi\u00f3n que afecta a ambos ojos y puede provocar una p\u00e9rdida permanente de la visi\u00f3n si no se trata a tiempo.\u00a0<\/p>","protected":false},"author":7,"featured_media":27358,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[8],"class_list":["post-27355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Birdshot Retinochoroidopathy (BSRC)<\/title>\n<meta name=\"description\" content=\"Learn how IVIG can help patients with birdshot chorioretinopathy, how this therapy works, and what you can expect during treatment with IVIG.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Birdshot Retinochoroidopathy (BSRC)\" \/>\n<meta property=\"og:description\" content=\"Learn how IVIG can help patients with birdshot chorioretinopathy, how this therapy works, and what you can expect during treatment with IVIG.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-22T23:27:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-22T23:27:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"IVIG for Birdshot Retinochoroidopathy (BSRC)\",\"datePublished\":\"2025-04-22T23:27:41+00:00\",\"dateModified\":\"2025-04-22T23:27:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/\"},\"wordCount\":1066,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/ivig-patient.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/\",\"name\":\"IVIG for Birdshot Retinochoroidopathy (BSRC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/ivig-patient.jpg\",\"datePublished\":\"2025-04-22T23:27:41+00:00\",\"dateModified\":\"2025-04-22T23:27:43+00:00\",\"description\":\"Learn how IVIG can help patients with birdshot chorioretinopathy, how this therapy works, and what you can expect during treatment with IVIG.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/ivig-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/ivig-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Patient receiving IVIG therapy for birdshot retinochoroidopathy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-birdshot-retinochoroidopathy-bsrc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Birdshot Retinochoroidopathy (BSRC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV para la retinocoroidopat\u00eda en perdigones (BSRC)","description":"Aprenda c\u00f3mo la IgIV puede ayudar a los pacientes con coriorretinopat\u00eda en perdigones, c\u00f3mo funciona esta terapia y qu\u00e9 puede esperar durante el tratamiento con IgIV.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG for Birdshot Retinochoroidopathy (BSRC)","og_description":"Learn how IVIG can help patients with birdshot chorioretinopathy, how this therapy works, and what you can expect during treatment with IVIG.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-04-22T23:27:41+00:00","article_modified_time":"2025-04-22T23:27:43+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"IVIG for Birdshot Retinochoroidopathy (BSRC)","datePublished":"2025-04-22T23:27:41+00:00","dateModified":"2025-04-22T23:27:43+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/"},"wordCount":1066,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/","name":"IgIV para la retinocoroidopat\u00eda en perdigones (BSRC)","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg","datePublished":"2025-04-22T23:27:41+00:00","dateModified":"2025-04-22T23:27:43+00:00","description":"Aprenda c\u00f3mo la IgIV puede ayudar a los pacientes con coriorretinopat\u00eda en perdigones, c\u00f3mo funciona esta terapia y qu\u00e9 puede esperar durante el tratamiento con IgIV.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg","width":1280,"height":853,"caption":"Patient receiving IVIG therapy for birdshot retinochoroidopathy"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-birdshot-retinochoroidopathy-bsrc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/zh\/"},{"@type":"ListItem","position":2,"name":"IVIG for Birdshot Retinochoroidopathy (BSRC)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Birdshot retinochoroidopathy (BRSC), also known by other terms like birdshot uveitis, birdshot chorioretinopathy, or HLA-A29 uveitis,\u00a0is a rare and potentially sight-threatening disease that affects both eyes and can lead to permanent vision loss if not treated early.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/ivig-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Birdshot retinochoroidopathy (BRSC), also known by other terms like birdshot uveitis, birdshot chorioretinopathy, or HLA-A29 uveitis,\u00a0is a rare and potentially sight-threatening disease that affects both eyes and can lead to permanent vision loss if not treated early.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27355"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27355\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27358"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27355"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}